Article
Towards consistent generation of pancreatic lineage progenitors from human pluripotent stem cells
30 Sept 2015
Abstract excerpt
Human pluripotent stem cells can in principle be used as a source of any differentiated cell type for disease modelling, drug screening, toxicology testing or cell replacement therapy. Type I diabetes is considered a major target for stem cell applications due to the shortage of primary human beta cells. Several protocols have been reported for generating pancreatic progenitors by in vitro differentiation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
